Bonhomme-Faivre L - Search Results

1

Effect of highly active antiretroviral therapy on tacrolimus pharmacokinetics in hepatitis C virus and HIV co-infected liver transplant recipients in the ANRS HC-08 study.

Teicher E, Vincent I, Bonhomme-Faivre L, Abbara C, Barrail A, Boissonnas A, Duclos-Vallée JC, Taburet AM, Samuel D, Vittecoq D. Teicher E, et al. Clin Pharmacokinet. 2007;46(11):941-52. doi: 10.2165/00003088-200746110-00002. Clin Pharmacokinet. 2007. PMID: 17922559 Clinical Trial.

2

Enfuvirtide: a safe and effective antiretroviral agent for human immunodeficiency virus-infected patients shortly after liver transplantation.

Teicher E, Abbara C, Duclos-Vallée JC, Antonini T, Bonhomme-Faivre L, Desbois D, Samuel D, Vittecoq D. Teicher E, et al. Liver Transpl. 2009 Oct;15(10):1336-42. doi: 10.1002/lt.21818. Liver Transpl. 2009. PMID: 19790146 Free article. Clinical Trial.

3

Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence.

Coilly A, Furlan V, Roche B, Barau C, Noël C, Bonhomme-Faivre L, Antonini TM, Roque-Afonso AM, Samuel D, Taburet AM, Duclos-Vallée JC. Coilly A, et al. Antimicrob Agents Chemother. 2012 Nov;56(11):5728-34. doi: 10.1128/AAC.01151-12. Epub 2012 Aug 20. Antimicrob Agents Chemother. 2012. PMID: 22908172 Free PMC article.

4

Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft.

Antonini TM, Furlan V, Teicher E, Haim-Boukobza S, Sebagh M, Coilly A, Bonhomme-Faivre L, Peytavin G, Roque-Afonso AM, Vittecoq D, Samuel D, Taburet AM, Duclos-Vallée JC. Antonini TM, et al. Among authors: bonhomme faivre l. AIDS. 2013 Oct 23;27(16):2655-7. doi: 10.1097/01.aids.0000432539.77711.f4. AIDS. 2013. PMID: 23939241

5

Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.

Antonini TM, Furlan V, Teicher E, Haim-Boukobza S, Sebagh M, Coilly A, Bonhomme-Faivre L, Roque-Afonso AM, Vittecoq D, Samuel D, Taburet AM, Duclos-Vallée JC. Antonini TM, et al. Among authors: bonhomme faivre l. AIDS. 2015 Jan 2;29(1):53-8. doi: 10.1097/QAD.0000000000000516. AIDS. 2015. PMID: 25387314

6

Effect of the ABCB1 3435C>T polymorphism on tacrolimus concentrations and dosage requirements in liver transplant recipients.

Bonhomme-Faivre L, Picard V, Saliba F, Abbara C, Fodil M, Chaunoy M, Farinotti R. Bonhomme-Faivre L, et al. Am J Health Syst Pharm. 2009 Sep 15;66(18):1645-51. doi: 10.2146/ajhp080396. Am J Health Syst Pharm. 2009. PMID: 19729569

7

Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation.

Sebagh M, Azoulay D, Roche B, Hoti E, Karam V, Teicher E, Bonhomme-Faivre L, Saliba F, Duclos-Vallée JC, Samuel D. Sebagh M, et al. Liver Transpl. 2011 Jul;17(7):798-808. doi: 10.1002/lt.22282. Liver Transpl. 2011. PMID: 21351239 Free article.

8

Enhanced oral bioavailability of paclitaxel by recombinant interleukin-2 in mice with murine Lewis lung carcinoma.

Abbara C, Rouchon C, Hosten B, Farinotti R, Bonhomme-Faivre L. Abbara C, et al. Drug Metabol Drug Interact. 2004;20(4):219-31. doi: 10.1515/dmdi.2004.20.4.219. Drug Metabol Drug Interact. 2004. PMID: 15663292

9

Cetuximab increases concentrations of irinotecan and of its active metabolite SN-38 in plasma and tumour of human colorectal carcinoma-bearing mice.

Chu C, Abbara C, Tandia M, Polrot M, Gonin P, Farinotti R, Bonhomme-Faivre L. Chu C, et al. Among authors: bonhomme faivre l. Fundam Clin Pharmacol. 2014 Dec;28(6):652-60. doi: 10.1111/fcp.12071. Epub 2014 Apr 16. Fundam Clin Pharmacol. 2014. PMID: 24588516

10

Development and validation of a method for the quantitation of Delta9 tetrahydrocannabinol in human plasma by high performance liquid chromatography after solid-phase extraction.

Abbara C, Galy R, Benyamina A, Reynaud M, Bonhomme-Faivre L. Abbara C, et al. J Pharm Biomed Anal. 2006 Jun 7;41(3):1011-6. doi: 10.1016/j.jpba.2006.01.017. Epub 2006 Feb 24. J Pharm Biomed Anal. 2006. PMID: 16500063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters